10-Q Filing

STRATA CRITICAL MEDICAL, INC. CIK: 1779128 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001779128-22-000047`
Period End Date	20220331
Filing Date	20220510
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	blde-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 32 Cash Flow Statement 65 Stockholders Equity 14 Comprehensive Income 8

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Short term investments, cost	`AvailableForSaleDebtSecuritiesAmortizedCostBasis`	$280.26M	USD	Point-in-time
Short term investments, cost	`AvailableForSaleDebtSecuritiesAmortizedCostBasis`	$268.70M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.60M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$1.68M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$630.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.02M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$5.55M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term investments (cost: March 31, 2022 - $268,702; December 31, 2021 - $280,263)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$266.56M	USD	Point-in-time
Short-term investments (cost: March 31, 2022 - $268,702; December 31, 2021 - $280,263)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$279.37M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.80M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.50M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$294.94M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.67M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.85M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$285.26M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.33M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.04M	USD	Point-in-time
Investment in joint venture	`InvestmentInJointVenture`	$200.00K	USD	Point-in-time
Investment in joint venture	`InvestmentInJointVenture`	$200.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$23.67M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.42M	USD	Point-in-time
Goodwill	`Goodwill`	$13.33M	USD	Point-in-time
Goodwill	`Goodwill`	$13.33M	USD	Point-in-time
Operating right-of-use asset	`OperatingLeaseRightOfUseAsset`	$713.00K	USD	Point-in-time
Operating right-of-use asset	`OperatingLeaseRightOfUseAsset`	$958.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$232.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$880.00K	USD	Point-in-time
Total assets	`Assets`	$335.88M	USD	Point-in-time
Total assets	`Assets`	$326.63M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$6.37M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$9.01M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$5.98M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$6.28M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$496.00K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$438.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.79M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$28.76M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$31.31M	USD	Point-in-time
Operating lease liability, long-term	`OperatingLeaseLiabilityNoncurrent`	$466.00K	USD	Point-in-time
Operating lease liability, long-term	`OperatingLeaseLiabilityNoncurrent`	$278.00K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$144.00K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$144.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$45.16M	USD	Point-in-time
Total liabilities	`Liabilities`	$44.51M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at March 31, 2022 and December 31, 2021. No shares issued and outstanding at March 31, 2022 and December 31, 2021.	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at March 31, 2022 and December 31, 2021. No shares issued and outstanding at March 31, 2022 and December 31, 2021.	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 400,000,000 authorized; 70,845,636 and 70,667,381 shares issued at March 31, 2022 and December 31, 2021, respectively.	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $0.0001 par value; 400,000,000 authorized; 70,845,636 and 70,667,381 shares issued at March 31, 2022 and December 31, 2021, respectively.	`CommonStockValue`	$7.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$368.68M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$370.79M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-898.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$281.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$291.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.70M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$326.63M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$335.88M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$26.63M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$9.27M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$23.71M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$7.80M	USD	1 Quarter
Software development	`ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost`	$289.00K	USD	1 Quarter
Software development	`ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost`	$835.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.98M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.83M	USD	1 Quarter
Selling and marketing	`SellingAndMarketingExpense`	$587.00K	USD	1 Quarter
Selling and marketing	`SellingAndMarketingExpense`	$1.80M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$40.32M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$13.50M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-13.69M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-2.55M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$4.00K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$264.00K	USD	1 Quarter
Realized loss from sale of short term investments	`GainLossOnInvestments`	-	USD	1 Quarter
Realized loss from sale of short term investments	`GainLossOnInvestments`	$-136.00K	USD	1 Quarter
Total other non-operating income	`NonoperatingIncomeExpense`	$2.68M	USD	1 Quarter
Total other non-operating income	`NonoperatingIncomeExpense`	$4.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.01M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.16	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.16	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.16	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.16	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	70.77M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.10M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.10M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	70.77M	shares	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.01M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.15M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$126.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.10M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$1.90M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-2.55M	USD	1 Quarter
Realized loss from sale of short term investments	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
Realized loss from sale of short term investments	`GainLossOnSaleOfInvestments`	$-136.00K	USD	1 Quarter
Unrealized foreign exchange gain / losses	`ForeignCurrencyTransactionGainLossUnrealized`	-	USD	1 Quarter
Unrealized foreign exchange gain / losses	`ForeignCurrencyTransactionGainLossUnrealized`	$5.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.71M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$828.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-473.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$465.00K	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-74.00K	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$648.00K	USD	1 Quarter
Operating lease assets/liabilities	`IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities`	$-1.00K	USD	1 Quarter
Operating lease assets/liabilities	`IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities`	$2.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.64M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.87M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-3.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$304.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-605.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.06M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$437.00K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$53.00K	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$265.00K	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	-	USD	1 Quarter
Proceeds from sales of short-term investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$11.70M	USD	1 Quarter
Proceeds from sales of short-term investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	-	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$11.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-53.00K	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$17.00K	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$21.00K	USD	1 Quarter
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00K	USD	1 Quarter
Deferred recapitalization costs related to the merger	`DeferredRecapitalizationCosts`	$1.77M	USD	1 Quarter
Deferred recapitalization costs related to the merger	`DeferredRecapitalizationCosts`	-	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.75M	USD	1 Quarter
Effect of foreign exchange rate changes on cash balances	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.00K	USD	1 Quarter
Effect of foreign exchange rate changes on cash balances	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$951.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.41M	USD	1 Quarter
Cash and cash equivalents and restricted cash - beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.18M	USD	Point-in-time
Cash and cash equivalents and restricted cash - beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34M	USD	Point-in-time
Cash and cash equivalents and restricted cash - beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23M	USD	Point-in-time
Cash and cash equivalents and restricted cash - beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.93M	USD	Point-in-time
Cash and cash equivalents and restricted cash - ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.18M	USD	Point-in-time
Cash and cash equivalents and restricted cash - ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34M	USD	Point-in-time
Cash and cash equivalents and restricted cash - ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23M	USD	Point-in-time
Cash and cash equivalents and restricted cash - ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$1.68M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$415.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.18M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.93M	USD	Point-in-time
Adoption of new leases under ASC 842 entered into during the period	`NoncashOrPartNoncashAdoptionOfAccountingStandardsUpdate`	$415.00K	USD	1 Quarter
Adoption of new leases under ASC 842 entered into during the period	`NoncashOrPartNoncashAdoptionOfAccountingStandardsUpdate`	$12.00K	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$10.00M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$281.47M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$291.37M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$7.70M	USD	Point-in-time
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$17.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$21.00K	USD	1 Quarter
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.01M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-1.00M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$10.00M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$281.47M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$291.37M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$7.70M	USD	Point-in-time

Comprehensive Income 8 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.01M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.24M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Foreign currency translation adjustments for the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$241.00K	USD	1 Quarter
Foreign currency translation adjustments for the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.22M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-12.02M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.